Adhesion molecules and cancer;Les molecules d'adhesion en cancerologie

Revue de Medecine Interne

Volumn 20, Issue 12, 1999, Pages 1099-1113

  Pierres, A ^a   Benoliel, A M ^a   Bongrand, P ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Adhesion; Binding strength; Inflammation; Kinetics; Metastasis; Tumoral invasiveness

Indexed keywords

BETA1 INTEGRIN; CD11B ANTIGEN; CD18 ANTIGEN; CD22 ANTIGEN; CD31 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; CELL ADHESION MOLECULE; COLLAGEN; FIBRONECTIN; HERMES ANTIGEN; HYALURONIC ACID; IMMUNOGLOBULIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; LAMININ; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; NERVE CELL ADHESION MOLECULE; P SELECTIN GLYCOPROTEIN LIGAND 1; SELECTIN; UVOMORULIN; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN;

CANCER; CANCER CONTROL; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; GENETIC TRANSFECTION; INFLAMMATION; KNOCKOUT GENE; REGULATORY MECHANISM; REVIEW; TISSUE DISTRIBUTION; TUMOR CELL; HUMAN; METASTASIS; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY;

CELL ADHESION; CELL ADHESION MOLECULES; HUMANS; INFLAMMATION; NEOPLASM METASTASIS; NEOPLASMS;

EID: 0033431651     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(00)87524-4     Document Type: Review

References (97)

1. Coman DR. Decreased mutual adhesiveness, a property of cells from squamous cell carcinomas. Cancer Res 1944; 4: 625-9.
2. Edwards JG, Campbell JA, Williams JF. Transformation by polyoma virus affects adhesion of fibroblasts. Nature N Biol 1971; 231: 147-8.
3. Winkelhake JL, Nicolson GL. Determination of adhesive properties of variant metastatic melanoma cells to BALB/3T3 cells and their virus-transformed derivatives by a monolayer attachment assay. J Natl Cancer Inst 1976: 56: 285-91.
4. Leung-Tack J, Capo C, DeLapeyrière O, Benoliel AM, Arnaud D, Bongrand P. Relationship between cellular adhesiveness and metastatic activity in polyomavirus-transformed FR3T3 rat cell lines. Int J cancer 1988; 42: 946-51.
5. Maslow De. Tabulation of results on the heterogeneity of cellular characteristics among cells from B16 mouse melanoma cell lines with different colonization potentials. A summary of sixty reports. Invasion Metastasis 1989; 9: 182-91.
6. Schrier PI, Bernards R, Vaessen Rtmj, Houweling A, Van der Erb AJ. Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature 1983; 305: 771-5.
7. Straüli P, Haemmerly G. The role of cancer cell motility in invasion. Cancer Metastasis Rev 1984; 3: 127-41.
8. Kim J, Yu W, KovalsKi K, Ossowski L. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 1998; 94: 353-62.
9. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996; 56: 4625-9.
10. Pierres A, Benoliel AM, Bongrand P. Interactions between biological surfaces. Current Opin Colloid & Interface Sci 1998; 3: 525-33.
11. Williams AF, t Barclay AN. The immunoglobulin superfamily - Domains for cell surface recognition. Annu Rev Immunol 1988; 6: 381-405.
12. Bongrand P, Malissen B. Quantitative aspects of T-cell recognition: From within the antigen-presenting cell to within the T cell. Bioessays 1988; 20: 412-22.
13. Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 1995; 57: 827-72.
14. Hynes RO. Integrins: Versatility, modulation and signaling in cell adhesion. Cell 1992; 69: 11-25.
15. Kansas GS. Selectins and their ligands: Current concepts and controversies. Blood 1996; 88: 3259-87.
16. Jentoft N. Why are proteins O-glycosylated? Trends Biochem Sci 1990; 15: 291-4.
17. Soler M, Merant C, Servant C, Fraterno M, Allasia C, Lissitzky JC, et al. Leukosialin (CD43) behavior during adhesion of human monocytic THP-1 cells to red blood cells. J Leukocyte Biol 1997; 61: 609-18.
18. Jackson DG. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 1995; 128: 673-85.
19. Barclay AN, Brown MH, Law SKA, McKnight AJ, Tomlinson MG, Van der Merwe PA. The Leucocyte Antigen Factsbook. London: Academic Press: 1997.
20. Arch R, Wirth K, HofMann M, Ponta H, Matzku S, Herrlich P, et al. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 1992; 257: 682-5.
21. Aberle H, ScHwartz H, Kemler R. Cadherin-catenin complex: Protein interactions and their implication for cadherin function. J Cell Biochem 1996; 61: 514-23.
22. Pigott R, Power C. The Adhesion Molecule Factsbook. London: Academic Press: 1993.
23. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998; 392: 190-3.
24. Pierres A, Benoliel AM, Bongrand P. Cell-Cell interactions. In: Baszkin A, Norde W, eds. Physical Chemistry of Biological Interfaces. New York: Marcel Dekker: 1998.
25. Patel KD, Nollert U, McEver RP. 1995 P-selectin must extend a sufficient length from the plasma membrane to mediate rolling of neutrophils. J Cell Biol 1995; 129: 1155-64.
26. Sabri S, Pierres A, Benoliel AM, Bongrand P. Influence of surface charges on cell adhesion: Difference between static and dynamic conditions. Biochem Cell Biol 1995; 73: 411-20.
27. Kaplanski G, Farnarier C, Tissot O, Pierres A, Benoliel AM, Alessi MC, et al. Granulocyte-endothelium initial adhesion: Analysis of transient binding events mediated by E-selectin in a laminar shear flow. Biophys J 1993; 64: 1922-33.
28. Alon R, Hammer DA, Springer TA. Lifetime of the p-selectin-carbohydrate bond and its response to tensile force in hydrodynamic flow. Nature 1995; 374: 539-42.
29. Pierres A, Benoliel A-, Bongrand P, Van der Merwe PA. Determination of the lifetime and force dependence of interactions of single bond formation between individual receptor-coated spheres and ligand-bearing surfaces. Proc Natl Acad Sci (Usa) 1996; 93: 15114-8.
30. von Andrian UH, Hassien SR, Nelson RD, Erlandsen SL, Butcher EC. A central role for microvillous receptor presentation in leukocyte adhesion under flow. Cell 1995; 82: 989-99.
31. Yap AS, Brieher WM, Pruschy M, Gumbiner BM. Lateral clusteringof the adhesive ectodomain: A fundamental determinant of cadherin function. Current Biol 1997; 7: 308-15.
32. Yauch RL, Felsenfeld DP, Kraeft SK, Chen LB, Sheetz MP, Hempler ME. Mutational evidence for control of cell adhesion through integrin diffusion/clustering independent of ligand binding. J Exp Med 1997; 186: 1347-55.
33. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins. Cell 1991; 151: 6338-46.
34. Wei JY, Shaw LM, Mercurio AM. Integrin signaling in leukocytes: Lessons from the alpha(6) beta(1) integrin. J Leukocyte Biol 1997; 61: 397-407.
35. Kinch MS, Petch L, Zhong CL, Burridge K. E-cadherin engagement stimulates tyrosine phosphorylation. Cell Adhesion & Commun 1996; 4: 425-37.
36. Babina M, Weber S, Mammeri K, Henz BM. Signal transduction via CD43 (leukosialin, sialophorin) and associated biological effects in a human mast cell line (HMC-1). Biochem Biophys Res Commun 1998; 243: 163-9.
37. Kaplanski G, Farnarier C, Benoliel AM, Foa C, Kaplanski S, Bongrand P. A novel role for E- And P-selectins: Shape control of endothelial cell monolayers. J Cell Sci 1994; 107: 2449-57.
38. Folkman J, Moscona A. Role of cell shape in growth control. Nature 1978; 273: 345-9.
39. Chen CS, Mrksich M, Huang S, Whitesides GM, Ingber De. Geometric control of cell life and death. Science 1997; 276: 1425-8.
40. Schwartz MA. Integrins, oncogenes and anchorage independence. J Cell Biol 1997; 139: 575-8.
41. Sastry SK, Lakonishok M, Thomas DA, Muschler J, Horwitz AF. Integrin α subunit ratios, cytoplasmic domains and growth factor synergy regulate muscle proliferation and differentiation. J Cell Biol 1996; 133: 169-84.
42. Stcroix B, Sheehan C, Rak JW, Florenes VA, Slingerland JM, Kerbel RS. E-cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27 (KIP1). J Cell Biol 1998; 142: 557-71.
43. Zutter MM, Santoro SA, Staatz WD, Tsung YL. Re-expression of the alpha(2)beta(1) integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci USA 1995; 92: 74115.
44. Anzai H, Kitadai Y, Bucana CD, Sanchez R, Omoto R, Fidler IJ. Intratumoral heterogeneity and inverse correlation between expression of E-cadherin and collagensase type IV in human gastric carcinomas. Differentiation 1996; 60: 119-27.
45. Grimm T, Johnson JP. Ectopic expression of carcinoembryonic antigen by a melanoma cell leads to changes in the transcription of two additional cell adhesion molecules. Cancer Res 1995; 55: 3254-7.
46. Foty RA, Sternberg MS. Measurement of tumor cell cohesion and suppression of invasion by E- or P-cadherin. Cancer Res 1997; 57: 5033-6.
47. Huttenlocher A, Kakonishok M, Kinder M, Wu S, Truong T, Knudsen KA, et al. Integrin and cadherin synergy regulates contact inhibition of migration and motile activity. J Cell Biol 1998; 141: 515-26.
48. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, et al. E-cadherin mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991; 113: 173-85.
49. Partin AW, Schoeniger JS, Mohler JL, Coffey DS. Fourier analysis of cell motility: Correlation of motility with metastatic potential. Proc Natl Acad Sci USA 1989; 86: 1254-8.
50. Palecek SP, Loftus JC, Ginsberg MH, Lauffenburger DA, HorWitz AF. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature 1997; 385: 537-40.
51. Pauli BU, Augustin-Voss HG, El-Sabban ME, Johnson RC, Hammer DA. Organ preference of metastasis. Cancer Metastasis Rev 1990; 9: 175-89.
52. Auerbach R, Alby L, Morrissey LW, Tu M, Joseph J. Expression of organ-specific antigens on capillary endothelial cells. Microvasc Res 1985; 29: 401-11.
53. Koike C, Oku N, Watanabe M, Tsjkada H, Kakiuchi T, Irimura T, et et al. Real-time PET analysis of metastatic tumor cell trafficking in vivo and its relationship to adhesion properties. Biochim Biophys Acta 1995; 1238: 99-106.
54. Humphries MJ, Olden K, Yamada KM. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 1986; 233: 467-70.
55. Tovari J, Paku S, Raso E, Pogany E, Kovalszky I, Ladanyi A, et al. Role of sinusoidal heparan sulfate proteoglycan in liver metastasis formation. Int J Cancer 1997; 71: 825-31.
56. Ruiz P, Dunon D, Sonnenberg A, Imhof BA. Suppression of mouse melanoma metastasis by EA-1, a monoclonal antibody specific for alpha 6 integrins. Cell Adhesion Commun 1993; 1: 67-81.
57. Matsuura N, PuzonMcLaughlin W, Irie A, Morikawa Y, KaKudo K, Takada Y. Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells. Am J Pathol 1996; 148: 55-61.
58. Kim YJ, Borsig L, Varki NM, Varki A. P selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci USA 1998; 95: 9325-30.
59. Biancone L, Araki M, Araki P, Vassalli P, Stamenkovic I. Redirection of tumor metastasis by expression of E-selectin in vivo. J Exp Med 1996; 183: 581-7.
60. Gunthert U, Hoffman M, Rudy W, Reber S, Zoller M, Haussmann I, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24.
61. Wang TN, Qian XH, Granick MS, Solomon MP, Rothman VL, Berger DH, et al. Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptor. Surgery 1996; 120: 449-54.
62. Dejana E, Martin-Padura I, Lauri D, Bernasconi S, Bani MR, Garofalo A, et al. Endothelial leukocyte adhesion molecule-1-dependent adhesion of colon carcinoma cells to vascular endothelium is inhibited by an antibody to Lewis fucosylated type I carbohydrate chain. Lab Invest 1992; 66: 324-30.
63. Scherbarth S, Orr FW. Intravital videomicroscopic evidence for regulation of metastasis by the hepatic microvasculature: Effetcts of interleukin I alpha on metastasis and the location of B16F1 melanoma cell arrest. Cancer Res 1997; 57: 4105-10.
64. Higashiyama A, Watanabe H, Okumura K, Yagita H. Involvement of tumor necrosis factor alpha and very late activation antigen 4 vascular cell adhesion molecule 1 interaction in surgical-stress-enhanced experimental metastasis. Cancer Immunol Immunother 1996; 42: 231-6.
65. 125i-5-iiodo-2'-deoxyuridine. J Natl Cancer Inst 1970; 45: 773-82.
66. Koop S, MacDonald IC, Luzzi K, Schmidt EE, Morris VL, Grattan M, et al. Fate of melanoma cells entering the microcirculation: Over 80% survive and extravasate. Cancer Res 1995; 55: 2520-3.
67. Morris VL, Koop S, MacDonald IC, Schmidt EE, Grattan M, Percy D, et al. Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth. Clin Exp Metastasis 1994; 12: 357-67.
68. Aoudjet F, Potworowski EF, Springer TA, Saint-Pierre Y. Protection from lymphoma cell metastasis in ICAM-1 mutant mice: A post-homing event. J Immunol 1998; 161: 2333-8.
69. Wesseling J, Van der Valk SW, Hilkens J. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/mucl. Mol Biol Cell 1996; 7: 565-77.
70. Fidler IJ. Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 1990; 50: 6130-8.
71. Banks RE, Gearing AJ, Hemingway IK, Norfolk DR, Perren TJ, Selby PJ. Circulating intercellular adhesion molecule-1 (ICAM- 1), e-sélectin and vascular cell adhesion molecule 1 (VCAM-1) in human malignancies. Br J Cancer 1993; 68: 122-4.
72. Sanchezrovira P, Jimenez E, Carracedo J, Barneto IC, Ramirez R, Aranda E. Serum levels of intercellular adhesion molecule 1 (ICAM-1) in patients with colorectal cancer: Inhibitory effect on cytotoxicity. Eur J Cancer 1998; 34: 394-8.
73. Wittig BM, Kaulen H, Thees R, Schmitt C, Knolle F, Stock J, et al. Elevated serum E-selectin in patients with liver metastases of colorectal cancer Eur J Cancer 1996; 32A: 1215-8.
74. Franzke A, Probstkepper M, Buer J, Duensing S, Hoffmann R, Wittke F, et al. Elevated pretreatment serum levels of soluble vascular adhesion molecule 1 and lactate deshydrogenase as predictors of survival in cutaneous metastatic malignant melanoma. Br J Cancer 1998; 78: 40-5.
75. Fortis C, Galli L, Consogno G, Cittercio G, Matteucci P, Scaglietti U, et al. Serum levels of soluble cell adhesion molecules (ICAM-1, VCAM-1, e-selectin) and of cytokine TNF-alpha increase during interleukin-2 therapy. Clin Immunol Immunopathol 1995; 76: 142-7.
76. Guo YJ, Liu GL, Wang XN, Jin D, Wu MC, Ma J, et al. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res 1994; 54: 422-6.
77. Schaider H, Rechweichselbraun I, Richtig E, Seidl H, Soyer HP, Smolle J, et al. Circulating adhesion molecules as pronostic factors for cutaneous melanoma. J Am Acad Dermatol 1997; 36: 209-13.
78. Nesbit M, Herlyn M. Adhesion receptors in human melanoma progression. Invasion & Metastasis 1994; 14: 131-46.
79. Moll R, Mitze M, Frixen UH, Birchmeier W. Differential loss of E-cadherin expression in infiltracting ductal and lobular breast carcinomas. Am J Pathol 1993; 143: 1731-42.
80. Miahle A, Louis J, Montlevier S, Peoch M, Pasquier D, Bosson JL, et al. Expression of e-cadherin and alpha-, beta- And gamma-catenins in human bladder carcinomas: Are they good pronostic factors? Invasion & Metastasis 1998; 17: 124-37.
81. Syrigos KN, Krausz T, Waxman J, PandHa H, Rowlinsonbusza G, Verne J, et al. E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: Correlation with histopathological grade, tumour stage and survival. Int J Cancer 1995; 64: 367-70.
82. Garcia S, Martini F, Demicco C, Andrac L, Sappa P, Hardwigsen J, et al. Pronostic value of E-cadherin immunodetection in hepatocellular carcinomas. Ann Pathol 1998; 18: 98-102.
83. Bukkholm IK, Nesland JM, Karesen R, Jacobsen U, Borresendale AL. E-cadherin and alpha-, beta- And gamma-catenin protein expression in relation to metastasis in human breast carcinoma. J Pathol 1998; 185: 262-6.
84. Friedrichs K, Ruiz P, Franke F, Gille I, Terpe HJ, Imhof BA. High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res 1995; 55: 901-6.
85. Benassi MS, Ragazzini P, Gamberi G, Sollazzo MR, Molendini L, Ferrari C, et al. Adhesion molecules in high-grade soft tissue sarcomas: Correlation to clinical outcome. Eur J Cancer 1998; 34: 496-502.
86. Price EA, Coombe DR, Murray JC. Beta-1 integrin mediate tumour cell adhesion to quiescent endothelial cells in vitro. Br J Cancer 1996; 74: 1762-66.
87. Giese A, Laube B, Zapf S, Mangold U, Westphal M. Glioma cell adhesion and migration on human brain sections. Anticancer Res 1998; 18: 2435-47.
88. Hieken TJ, Farolan M, Ronan SG, Shilkaitis A, Wild L, Dasgupta TK. Beta 3 integrin expression in melanoma predicts subsequent metastasis. J Surg Res 1996; 63: 169-73.
89. Hieken TJ, Ronan SG, Farolan N, Shilkaitis AL, Dasgupta TK. Beta 1 integrin expression: A marker of lymphatic metastases in cutaneous malignant melanoma. Anticancer Res 1996; 16: 2321-4.
90. Danen EHJ, Vankraats AA, Cornelissen Imha, Ruiter DJ, Vanmuijen GNP. Integrin beta 3 cDNA transfection into a highly metastatic alpha v beta 3-negative human melanoma cell line inhitits invasion and experimental metastasis. Biochem Biophys Res Commun 1996; 226: 75-81.
91. Adachi M, Taki T, Huang CL, Higashiyama M, DOi O, Tsuji T, et al. Reduced integrin alpha 3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung. J Clin Oncol 1998; 16: 1060-7.
92. Zoller M. CD44: Physiological expression of distinct isoforms as evidence for organ-specific metastasis formation. J Mol Med 1995; 73: 425-38.
93. Yamaguchi A, Urano T, Goi T, Saito M, Takeuchi K, Hirose K, et al. Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients. J Clin Oncol 1996; 14: 1122-7.
94. Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Scand J Gastroenterol 1998; 33: 301-9.
95. McGuckin MA, Walsh MD, Hohn BG, Ward BG, Wright RG. Prognostic significance of MUC1 epithelial mucin expression in breast cancer. Hum Pathol 1995; 26: 432-9.
96. Horwitz MA, Maxfield FR. Legionella pneumophila inhibits acidification of its phagosome in human monocytes. J Cell Biol 1984; 99: 1936-43.
97. Antoine JC, Prina E, Jouanne C, Bongrand P. Parasitophorous vacuoles of Leishmania amazonensis-infected macrophages maintain an acidic ph. Infect Immun 1990; 58: 779-87.